Vanguard Health Care remains in strong hands after a gradual and smooth portfolio manager transition, while its well-established and appealing process remains intact. The strategy maintains its People and Process Pillar ratings of Above Average.
Vanguard Health Care Fund Investor Shares VGHCX
- NAV / 1-Day Return 214.14 / −1.19 %
- Total Assets 39.7B
-
Adj. Expense Ratio
0.330%
- Expense Ratio 0.330%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Large Blend
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 1.00%
- Turnover 47%
USD | NAV as of Sep 05, 2026 | 1-Day Return as of Sep 05, 2026, 10:02 AM GMT+0
Morningstar’s Analysis VGHCX
Will VGHCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 41.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 8.83 | 3B | Healthcare |
Merck & Co Inc | 6.05 | 2B | Healthcare |
AstraZeneca PLC | 4.85 | 2B | Healthcare |
Johnson & Johnson | 4.50 | 2B | Healthcare |
UnitedHealth Group Inc | 4.41 | 2B | Healthcare |
GSK PLC | 2.97 | 1B | Healthcare |
CVS Health Corp | 2.59 | 1B | Healthcare |
Edwards Lifesciences Corp | 2.49 | 967M | Healthcare |
Vertex Pharmaceuticals Inc | 2.41 | 939M | Healthcare |
Intuitive Surgical Inc | 2.37 | 922M | Healthcare |